Did ANI Pharmaceuticals’ (ANIP) Upgraded 2025 Outlook Just Shift Its Investment Narrative?

2025-11-08T10:50:45-08:00

ANI Pharmaceuticals recently raised its full-year 2025 earnings guidance, now expecting net revenue of US$854 million to US$873 million, up from the previous forecast of US$818 million to US$843 million, ...

Did ANI Pharmaceuticals’ (ANIP) Upgraded 2025 Outlook Just Shift Its Investment Narrative?2025-11-08T10:50:45-08:00

e.l.f Beauty Shares Plunge. Should Investors Buy the Stock on the Dip or Stay Away?

2025-11-08T10:50:11-08:00

The market's reaction to management's guidance looks overly harsh. It has been a roller-coaster ride for shareholders in e.l.f. Beauty (ELF 3.79%) over the past year. After a steep drop ...

e.l.f Beauty Shares Plunge. Should Investors Buy the Stock on the Dip or Stay Away?2025-11-08T10:50:11-08:00
Go to Top